Iovance Biotherapeutics

-$0.40 (-1.75%) Today

-$0.37 (-1.64%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.

About IOVA

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.

CEO

Frederick G. Vogt

Employees

241

Headquarters

San Carlos, California

Founded

2007

IOVA Key Statistics

Market Cap

3.44B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.87M

High Today

$23.50

Low Today

$22.49

Open Price

$22.95

Volume

1.38M

52 Week High

$54.21

52 Week Low

$15.88

Analyst Ratings

79%

of 14 ratings

Buy

78.6%

Hold

21.4%

Sell

IOVA Earnings

-$0.55

-$0.37

-$0.18

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Available Aug 5, After Hours